189 related articles for article (PubMed ID: 25327565)
1. Epithelial-mesenchymal transition in prostate cancer is associated with quantifiable changes in nuclear structure.
Verdone JE; Parsana P; Veltri RW; Pienta KJ
Prostate; 2015 Feb; 75(2):218-24. PubMed ID: 25327565
[TBL] [Abstract][Full Text] [Related]
2. Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts.
Hernandez JR; Kim JJ; Verdone JE; Liu X; Torga G; Pienta KJ; Mooney SM
Med Oncol; 2015 May; 32(5):159. PubMed ID: 25850653
[TBL] [Abstract][Full Text] [Related]
3. [Characterization of prostate cancer cell lines and their epithelial-mesenchymal transition in subcutaneous tumors].
Zhao L; Jiang YG; Ma J; Luo Y; Zhao JH
Zhonghua Nan Ke Xue; 2011 Apr; 17(4):314-7. PubMed ID: 21548207
[TBL] [Abstract][Full Text] [Related]
4. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
[TBL] [Abstract][Full Text] [Related]
5. FTIR microspectroscopy and multivariate analysis facilitate identification of dynamic changes in epithelial-to-mesenchymal transition induced by TGF-β in prostate cancer cells.
Karmakar D; Lahiri P; Bedi M; Ghosh A; Ghosh A; Barui A; Varshney SK; Lahiri B; Sengupta S
J Cell Biochem; 2023 Jun; 124(6):849-860. PubMed ID: 37158093
[TBL] [Abstract][Full Text] [Related]
6. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
7. SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin.
Deep G; Jain AK; Ramteke A; Ting H; Vijendra KC; Gangar SC; Agarwal C; Agarwal R
Mol Cancer; 2014 Feb; 13():37. PubMed ID: 24565133
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of Snail through AKT/GSK-3β signaling pathway is required for TNF-α-induced epithelial-mesenchymal transition in prostate cancer PC3 cells.
Wang H; Fang R; Wang XF; Zhang F; Chen DY; Zhou B; Wang HS; Cai SH; Du J
Eur J Pharmacol; 2013 Aug; 714(1-3):48-55. PubMed ID: 23769744
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells.
Kong D; Wang Z; Sarkar SH; Li Y; Banerjee S; Saliganan A; Kim HR; Cher ML; Sarkar FH
Stem Cells; 2008 Jun; 26(6):1425-35. PubMed ID: 18403754
[TBL] [Abstract][Full Text] [Related]
10. Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization.
Cai G; Wu D; Wang Z; Xu Z; Wong KB; Ng CF; Chan FL; Yu S
Oncogene; 2017 Jan; 36(4):546-558. PubMed ID: 27321179
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
12. Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.
Parsana P; Amend SR; Hernandez J; Pienta KJ; Battle A
BMC Cancer; 2017 Jun; 17(1):447. PubMed ID: 28651527
[TBL] [Abstract][Full Text] [Related]
13. Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis.
Ruscetti M; Quach B; Dadashian EL; Mulholland DJ; Wu H
Cancer Res; 2015 Jul; 75(13):2749-59. PubMed ID: 25948589
[TBL] [Abstract][Full Text] [Related]
14. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
[TBL] [Abstract][Full Text] [Related]
15. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
Al-Azayzih A; Gao F; Somanath PR
Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
[TBL] [Abstract][Full Text] [Related]
16. Role of epithelial mesenchymal transition in prostate tumorigenesis.
Khan MI; Hamid A; Adhami VM; Lall RK; Mukhtar H
Curr Pharm Des; 2015; 21(10):1240-8. PubMed ID: 25506896
[TBL] [Abstract][Full Text] [Related]
17. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells.
Li Y; Li Q; Li D; Gu J; Qian D; Qin X; Chen Y
Life Sci; 2021 Jan; 264():118638. PubMed ID: 33164833
[TBL] [Abstract][Full Text] [Related]
18. Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells.
Slabáková E; Kharaishvili G; Smějová M; Pernicová Z; Suchánková T; Remšík J; Lerch S; Straková N; Bouchal J; Král M; Culig Z; Kozubík A; Souček K
Oncotarget; 2015 Nov; 6(34):36156-71. PubMed ID: 26416355
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
Celià-Terrassa T; Meca-Cortés O; Mateo F; Martínez de Paz A; Rubio N; Arnal-Estapé A; Ell BJ; Bermudo R; Díaz A; Guerra-Rebollo M; Lozano JJ; Estarás C; Ulloa C; Álvarez-Simón D; Milà J; Vilella R; Paciucci R; Martínez-Balbás M; de Herreros AG; Gomis RR; Kang Y; Blanco J; Fernández PL; Thomson TM
J Clin Invest; 2012 May; 122(5):1849-68. PubMed ID: 22505459
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance.
Stark TW; Hensley PJ; Spear A; Pu H; Strup SS; Kyprianou N
Prostate; 2017 Dec; 77(16):1583-1591. PubMed ID: 29063620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
